Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Toole

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
The British Journal of Dermatology|May 18, 2006
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgarisK Kragballe, J Austad, L Barnes, et al.
Nature|November 22, 1984
Molecular cloning of a cDNA encoding human antihaemophilic factorJ J Toole, J L Knopf, J M Wozney, et al.
Biotechnology (Reading, Mass.)|January 1, 1992
Molecular cloning of a cDNA encoding human antihaemophilic factor. 1984J J Toole, J L Knopf, J M Wozney, et al.
Dermatology (Basel, Switzerland)|December 1, 2006
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgarisK Kragballe, J Austad, L Barnes, et al.
Clinical Chemistry and Laboratory Medicine|March 14, 2026
Analytical performance of an automated LC-MS/MS analyzer for determination of vitamin D concentration in blood plasma and serumKatie Weaver, Tom de Waal, Michael Vogeser, et al.
JAMA|July 14, 2004
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trialJoel E Gallant, Schlomo Staszewski, Anton L Pozniak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2006
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysisAnton L Pozniak, Joel E Gallant, Edwin DeJesus, et al.
The New England Journal of Medicine|January 20, 2006
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIVJoel E Gallant, Edwin DeJesus, José R Arribas, et al.
Journal of Viral Hepatitis|December 22, 1999
A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infectionR J Gilson, K B Chopra, A M Newell, et al.
Annals of Internal Medicine|September 11, 2003
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trialKathleen Squires, Anton L Pozniak, Gerald Pierone, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
The British Journal of Dermatology|May 18, 2006
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgarisK Kragballe, J Austad, L Barnes, et al.
Nature|November 22, 1984
Molecular cloning of a cDNA encoding human antihaemophilic factorJ J Toole, J L Knopf, J M Wozney, et al.
Biotechnology (Reading, Mass.)|January 1, 1992
Molecular cloning of a cDNA encoding human antihaemophilic factor. 1984J J Toole, J L Knopf, J M Wozney, et al.
Dermatology (Basel, Switzerland)|December 1, 2006
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgarisK Kragballe, J Austad, L Barnes, et al.
Clinical Chemistry and Laboratory Medicine|March 14, 2026
Analytical performance of an automated LC-MS/MS analyzer for determination of vitamin D concentration in blood plasma and serumKatie Weaver, Tom de Waal, Michael Vogeser, et al.
JAMA|July 14, 2004
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trialJoel E Gallant, Schlomo Staszewski, Anton L Pozniak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2006
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysisAnton L Pozniak, Joel E Gallant, Edwin DeJesus, et al.
The New England Journal of Medicine|January 20, 2006
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIVJoel E Gallant, Edwin DeJesus, José R Arribas, et al.
Journal of Viral Hepatitis|December 22, 1999
A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infectionR J Gilson, K B Chopra, A M Newell, et al.
Annals of Internal Medicine|September 11, 2003
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trialKathleen Squires, Anton L Pozniak, Gerald Pierone, et al.
Pageof 15